Elutia Inc. financial data

Symbol
ELUT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
12510 Prosperity Drive, Suite 370, Silver Spring, MD
State of incorporation
DE
Fiscal year end
December 31
Former names
AZIYO BIOLOGICS, INC. (to 8/14/2023)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 75.3 % -27.7%
Quick Ratio 9.97 % -52.1%
Debt-to-equity -196 % +66.5%
Return On Equity 143 % -47.4%
Return On Assets -149 % -166%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 15M USD -51.8%
Weighted Average Number of Shares Outstanding, Basic 24.9M shares +53.5%
Weighted Average Number of Shares Outstanding, Diluted 24.9M shares +53.5%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 4.11M USD -22.4%
Selling and Marketing Expense 12M USD -21.7%
General and Administrative Expense 16.5M USD +12.1%
Operating Income (Loss) -32.9M USD +5.37%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -70.1M USD -94.1%
Income Tax Expense (Benefit) 1K USD -97.1%
Net Income (Loss) Attributable to Parent -65.2M USD -92.2%
Earnings Per Share, Basic -2.81 USD/shares -26%
Earnings Per Share, Diluted -2.81 USD/shares -26%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 18.2M USD +95.7%
Accounts Receivable, after Allowance for Credit Loss, Current 3.52M USD -44.3%
Inventory, Net 3.12M USD -66.4%
Assets, Current 30.4M USD -16%
Property, Plant and Equipment, Net 159K USD -89.2%
Operating Lease, Right-of-Use Asset 1.4M USD
Intangible Assets, Net (Excluding Goodwill) 9.97M USD -25.4%
Other Assets, Noncurrent 1.42M USD +4.1%
Assets 41.9M USD -19.9%
Accounts Payable, Current 3.14M USD -2.7%
Accrued Liabilities, Current 7.34M USD -37.4%
Liabilities, Current 39.8M USD -7.14%
Operating Lease, Liability, Noncurrent 711K USD
Other Liabilities, Noncurrent 1.57M USD +348%
Liabilities 106M USD +42.7%
Retained Earnings (Accumulated Deficit) -222M USD -41.7%
Stockholders' Equity Attributable to Parent -64.3M USD -191%
Liabilities and Equity 41.9M USD -19.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.64M USD +48.9%
Net Cash Provided by (Used in) Financing Activities -4.07M USD -2849%
Net Cash Provided by (Used in) Investing Activities -15K USD +91.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 18.2M USD +95.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.54M USD +344%
Deferred Tax Assets, Valuation Allowance 39M USD +22.4%
Deferred Tax Assets, Gross 39.5M USD +20.6%
Operating Lease, Liability 1.4M USD
Payments to Acquire Property, Plant, and Equipment 15K USD -91.8%
Lessee, Operating Lease, Liability, to be Paid 281K USD +18.6%
Property, Plant and Equipment, Gross 753K USD -9.28%
Operating Lease, Liability, Current 275K USD +18.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 700K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 600K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6K USD +20%
Lessee, Operating Lease, Liability, to be Paid, Year Three 100K USD
Deferred Tax Assets, Operating Loss Carryforwards 23.3M USD +18.1%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 157M USD +17.1%
Amortization of Intangible Assets 3.4M USD +0.03%
Depreciation, Depletion and Amortization 864K USD -8.77%
Share-based Payment Arrangement, Expense 5.98M USD +165%
Interest Expense 5.68M USD +6.49%